Valeant Pharmaceuticals Purpose X: A Follow Upwardly On The Sale Of Facial Injectables

This is portion 10 of a long serial on Valeant Pharmaceuticals - a major companionship inward the speciality pharmaceutical infinite - in addition to 1 that has cumulatively undertaken many billions inward acquisitions.

The serial was prompted past times their biggest attempted acquisition to engagement - an unsolicited in addition to ultimately hostile bid for Allergan - the maker of Botox.

If yous get got non been next yous tin review the serial here: Part I, Part II, Part III, Part IIIa, Part IV, Part V, Part VI, Part VII, Part VIII and Part IX.

--

In my terminal postal service on Valeant Pharmaceuticals I observed that the companionship had blamed its turn a profit immature adult woman on the sale of its Facial Injectables draw of piece of employment organisation to Galderma. Specifically they stated that [Valeant] had built into our previous guidance $230 1 M one thousand of revenue in addition to $0.50 per portion cash EPS for the minute one-half of the twelvemonth from the (now sold) injectables business.

I calculated that in that place were 340 1 M one thousand shares outstanding in addition to and hence for six months they were forgoing 170 1 M one thousand of turn a profit past times selling that business. This is 340 1 M one thousand annualized in addition to the draw of piece of employment organisation was sold for $1400 million. 

This meant the draw of piece of employment organisation was sold at roughly 4 times earnings.

Michael Pearson stated on the conference telephone telephone that were able to "realize the total value for these products" in addition to and hence I idea in that place must live an error. After all Michael Pearson [the CEO of Valeant] is a clever in addition to rational human in addition to he would non sell at in addition to hence depression a price.

The post-tax in addition to fees sales toll is considerably lower than $1400 1 M one thousand - in addition to and hence the sale looks fifty-fifty to a greater extent than insane. press unloose announcing the closure of the sale (dated 10 July 2014) Michael Pearson stated:

Humberto Antunes , CEO of Galderma, has embraced our commercial squad in addition to I know he volition proceed our efforts to construct potent relationships amongst the healthcare leaders inward this industry.

It sure enough sounds similar the sales forcefulness went amongst Galderma amongst the products in straight contradiction of the JPMorgan broker article.

This impression is farther enhanced inward past times Valeant's conference telephone telephone where they blame a dramatic intra-quarter autumn inward the sales of Facial Injectable production on the sale. To quote:

As expected, the aesthetics draw of piece of employment organisation deteriorated inward Q2. The physicians were confused equally to what products nosotros wanted them to buy: our legacy Medicis products or our soon-to-have Allergan products. The uncertain condition of our MVP Program besides created concern for the doctors. Our reps in addition to management were focused on pleasing their novel owners in addition to belongings dorsum sales until they worked for the novel company, in addition to our competitors were discounting heavily in addition to disproportionately trying to accept a temporary portion to demonstrate weakness inward our business. 

As a result, our sales dropped unopen to 40% inward Q2. Fortunately, these assets are forthwith safely inward Galderma's hands, in addition to nosotros tin forthwith focus on the balance of our business.

You run into (as per the highlighted section) the injectables sales forcefulness were belongings dorsum sales, focused on pleasing their novel owners. Which of course of teaching implied they had novel owners.

Galderma's management are besides clear that well-nigh of the sales infrastructure went amongst the products to Galderma. Galderma's press release states:

At Galderma people come upwards first. We are thrilled to accept on board the experienced teams from Valeant Aesthetics and, to a greater extent than than ever, our intent is to save the character of the long-lasting human relationship built amongst doctors. 

The JPMorgan annotation quoted inward a higher house explicitly states that the sales forcefulness stayed amongst Valeant. Michael Pearson soundless has repeatedly stated the sales infrastructure went amongst the novel owners.

Just for kicks I get got examined many profiles on LinkedIn.com - checking the exertion amongst functions amongst the property sale. It is pretty clear - the sales infrastructure went amongst the asset.

Analysts brand mistakes (I practice regularly).

I gave an early on draft of this spider web log postal service to Chris Schott, Jessica Fye, Wendy Lin in addition to Dana Flemish region (the JPMorgan analysts) in addition to expected them to come upwards out amongst an explanation consistent amongst the statements of Valeant in addition to Galderma management (or for that affair consistent amongst easily obtained information on LinkedIn).

I volition impress that explanation when it is forwarded to me. But without farther explanation the guidance provided past times Valeant continues to brand no sense. And the implication is devastating. Either Valeant is only making upwards its guidance numbers or they sold a growing draw of piece of employment organisation at nether iv times earnings.

John